Interconnection of glycolysis with other metabolic pathways
Interconnection of glycolysis with other metabolic pathways. (A) Regulation of cellular metabolism by PI3K/AKT/mTOR pathway and AMPK. (B) Glycolysis pathway. Hexokinase 2 (HK) phosphorylates at glucose to obtain glucose-6 phosphate (G6P), which is converted to fructose-6-phosphate (F6P) by glucose-6-phosphate isomerase (G6PI). The F6P is converted to fructose-1,6-biphosphate (F1,6BP), subsequently the F1,6BP, F1,6BP are cut by aldolase (Aldo) to produce dihydroxyacetone phosphate (DHAP), and glyceraldehyde-3-phosphate (GA3P). GA3P is transformed by glyceraldehyde-3-phosphate dehydrogenase (GA3PDH) to 1,3-bisphosphoglycerate (1,3BPG), which is converted to 3-phosphoglycerate (3PG) by a phosphoglycerate kinase (PGK). 3PG is converted to 2-phosphoglycerate (2PG) by phosphoglycerate mutase (PGM). Next, 2PG is metabolized to phosphoenolpyruvate (PEP) by enolase (ENO). PEP forms pyruvate (Pyr) by the action of pyruvate kinase (PKM2). Pyr is transformed into Lactate and H+ by Lactate dehydrogenase and acetyl-CoA by the pyruvate dehydrogenase (PDH (PDH). (C) The G6P could be redirected to the pentose phosphate pathway (PPP). (D) DHAP could be redirected to the triacylglycerol synthesis. 3PG can be a precursor by ceramide synthesis. (E) Krebs cycle. The TCA cycle starts with the combination of acetyl-CoA and oxaloacetate (OA) to produce citrate (CIT). CIT is converted into isocitrate (ICIT), which is transformed at α-ketoglutarate (αKG) with the NADH generation, Subsequently, the αKG is converted at succinyl-CoA (Su-CoA) producing NADH. Su-CoA is transformed at succinate (SCN) with the production of GTP. Next, the SCN is converted at fumarate (FM) and releases FADH2. The FM is metabolized to malate (ML), subsequently, the ML is transformed to OA and generates NADH. The OA again reacts with Ac-CoA to continue the cycle. Citrate obtained from the TCA cycle is released at cytosol and converted to Ac-CoA and OA by ATP-citrate lyase (ACLY). (F) The Ac-CoA is a substrate by de novo the fatty acids and cholesterol synthesis. (G) β-Oxidation. The fatty acids produced by De novo lipogenesis synthesis can be metabolized by the β-Oxidation pathway. Abbreviation: Phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), mammalian target of rapamycin (mTOR), 5′AMP-activated protein kinase (AMPK), hypoxia inducible factor-1 (HIF-1), Sterol Regulatory Element Binding Proteins (SREBP-1), phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB4,-3), pyruvate dehydrogenase kinase1 (PDHK1), phosphofructokinase Type 1 (PFK1), citrate synthase (CS), aconitase (AC), isocitrate dehydrogenase 1, -2 (IDH1,-2), α-ketoglutarate dehydrogenase enzyme complex (α-KGDH), succinyl CoA synthetase (SCS), succinate dehydrogenase (SDH), fumarate hydratase (FH), Malate dehydrogenase (MDH2), Malic Enzyme (ME), ATP-citrate lyase (ACL), acetyl-CoA carboxylases (ACC), acetyl-CoA acetyltransferase (ACAT), fatty acid synthase (FASN), Stearoyl-CoA Desaturase (SCD), Hydroxymethylglutaryl-CoA Reductase (HMGCR), HMGCS: Hydroxymethylglutaryl-CoA Synthase (HMGCS), glycerol-3-phosphate acyltransferases (GPATs), generating lysophosphatidic acid, 1-acylglycerol-3-phosphate acyltransferases (AGPATs), diglyceride acyltransferase (DGAT) phosphatidate phosphatase (PAP), glutamine (Gln), glutamate (Glu). ↑ activation, ⊥ inhibition. The figure was created with BioRender.com
Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma (2023)
Cristina Trejo-Solis, et al. Int J Mol Sci. 2023 Dec;24(24). Figure: F1.